Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerPolicy UpdatesDurable Medical Equipment (DME)CareSource E0466 Ventilator Coverage Update | Open…
    Ask Trek AI about this page
    CurrentCareSourcePolicy PASSE-MM-1702

    Non-Invasive Home Mechanical Ventilation (E0466)

    Customize your policy alerts

    Sign up for CareSource Policy PASSE-MM-1702 alerts

    Get alerted when Policy PASSE-MM-1702 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical necessity, prior authorization, documentation, and continued rental coverage for noninvasive home ventilators (HCPCS E0466) for Arkansas Medicaid members with stable chronic respiratory failure or other qualifying conditions. It distinguishes ventilator-level support from CPAP, BiPAP, and other respiratory assist devices.

    Policy Summary
    PayerCareSource
    PolicyNon-Invasive Home Mechanical Ventilation (E0466)
    Policy CodePolicy PASSE-MM-1702
    Change TypeRevision
    Effective DateNov 1, 2026
    Last ReviewJul 30, 2025
    Next Review DateN/A
    Key ActionSubmit prior authorization with the completed DMS-679 form, prescription, clinical records, ventilator settings, and evidence of required medical dependence and pulmonary oversight.
    SourceLink
    POLICY UPDATE CHANGES

    Added conditions of coverage and documentation requirements in section E.II.

    Revised definitions and clarified the distinction between respiratory assist devices and noninvasive home ventilators.

    Added trained caregiver availability as a respiratory stability requirement.

    Updated exclusions for nonqualifying E0466 use.

    Removed the prior respiratory stability requirement related to oxygen level.

    E0466Covered noninvasive home ventilator
    6 hours/dayRequired daily ventilator use
    3 monthsInitial approval period
    Every 6 monthsContinued review frequency
    30 daysRequired device-data period
    Not coveredNonqualifying sole use

    Coverage Criteria

    Initial qualifying medical conditions

    Covered when one qualifying clinical condition and all applicable condition-specific criteria are met.

    Qualifying clinical condition

    • Congenital central hypoventilation syndrome: Member has congenital central hypoventilation syndrome.
    • Chronic lung disease of infancy: Member has chronic lung disease of infancy, such as bronchopulmonary dysplasia, and cannot maintain acceptable pH and PCO2 without ventilator support.
    • COPD

      • COPD qualifying condition: Chronic stable hypercapnia with PaCO2 >45 mm Hg; persistent hypercapnia during spontaneous breathing after hospitalization with PaCO2 >45 mm Hg; or palliative care for end-stage disease with an advance directive declining intubation.PaCO2 >45 mm Hg (6.0 kPa)
    • Neuromuscular disorder with respiratory failure

      • Neuromuscular disorder: Amyotrophic lateral sclerosis, congenital muscular dystrophy, Duchenne muscular dystrophy, mitochondrial myopathy, myotonic dystrophy, postpolio syndrome, spinal cord syndrome, spinal muscular atrophy, or another neuromuscular disorder accompanied by chronic respiratory failure.
      • Respiratory failure evidence: Daytime PCO2 >45 mm Hg; forced vital capacity <50% of predicted; forced vital capacity <80% of predicted with symptoms of respiratory failure; maximum inspiratory pressure 60 cm H2O or lower; maximum sniff nasal inspiratory pressure <40 cm H2O; oxygen saturation <88% for 5 consecutive nocturnal minutes; or qualifying sleep hypoventilation on polysomnography.
    • Obesity hypoventilation syndrome

      • CPAP unsuccessful or not appropriate: Comorbid sleep-related hypoventilation; intolerance of CPAP pressure; lack of resolution of hypercarbia, nocturnal desaturation, and OSA after 3 months of CPAP; or OSA despite CPAP 15 cm H2O that responds to BiPAP.
      • Sleep-disordered breathing or hypoventilation: Apnea-hypopnea index of 5 or greater; increase in PaCO2 during sleep of more than 10 mm Hg above the awake value; or significant oxygen desaturation not explained by obstructive apneas or hypopneas.
    • OSA in child or adolescent: Child or adolescent has mild OSA with a qualifying comorbidity or symptom, moderate or severe OSA, or residual AHI >5 after adenotonsillectomy.Mild OSA AHI 1-5; moderate/severe OSA AHI >5; residual AHI >5 after adenotonsillectomy

      Qualifying mild OSA factors include achondroplasia, behavioral problems, cardiovascular disease, Chiari malformation, craniofacial abnormalities, Down syndrome, excessive daytime sleepiness, impaired cognition, inattention or hyperactivity, mucopolysaccharidoses, neuromuscular disorder, or Prader-Willi syndrome.

    • Restrictive chest wall disorder with respiratory failure

      • Chest wall disorder: Asphyxiating thoracic dystrophy, kyphoscoliosis, or another chest wall disorder accompanied by chronic respiratory failure.
      • Respiratory failure evidence: Nocturnal oxygen saturation <88% for 5 consecutive minutes; daytime PCO2 >45 mm Hg; forced vital capacity <50% of predicted; forced vital capacity <80% of predicted with symptoms of respiratory failure; maximum inspiratory pressure 60 cm H2O or lower; or qualifying adult or child sleep hypoventilation on polysomnography.

    Respiratory stability for home use

    All respiratory-stability criteria must be met.

    Stable respiratory status

    • Safe interface: Airway interface is safe with an acceptable noninvasive fit.
    • Appropriate airway pressure: BiPAP expiratory positive airway pressure requirement is <=10 cm H2O; child CPAP pressure requirement is <=15 cm H2O; or ventilator positive end-expiratory pressure requirement is <=10 cm H2O.
    • Stable settings: Settings are stable on the chosen device.
    • No continuous invasive monitoring: Continuous invasive monitoring is not required.
    • Trained caregivers are available.

    Need for ventilator-level support beyond CPAP or BiPAP

    At least one criterion must show that CPAP or standard BiPAP is not clinically appropriate or lacks required capabilities.

    Need exceeds respiratory-assist-device capability

    • Failure of simple BiPAP: Chronic respiratory insufficiency fails to improve with a simple BiPAP device.
    • Pediatric CPAP limitation: Infant or child does not meet the minimum body-weight requirement for a CPAP device.
    • Pediatric simple BiPAP limitation: Infant or child is not appropriate for simple BiPAP because of inappropriate breath rates, circuits, inspiratory flows, minimum weight, pressure range, tidal-volume range, trigger delay, or trigger sensitivity.
    • Required functionality unavailable: Required alarms, daytime mouthpiece ventilation, an appropriate pressure range, or volume-assured pressure support or volume-control mode is unavailable with simple BiPAP.
    • Mobility: A portable ventilator is required for mobility.
    • Cough assistance: The ventilated patient requires cough assistance through a volume ventilator's breath-stacking capability.
    • Continuous ventilation: Ventilation is required 24 hours per day.

    Continued medical necessity

    Continued coverage requires reestablishment of medical necessity every 6 months after the initial 3-month determination.

    Continued device use

    • Timely reevaluation: Treating medical professional reevaluation occurs no earlier than 61 days after therapy initiation.
    • Persistent disease: Records document persistence of the disease process for which the home ventilator was prescribed.
    • Compliance and benefit: Medical records document that the member is compliant with and benefiting from the home ventilator.
    • Device utilization: At least 30 consecutive days of device data beginning after day 31 show average use of at least 6 hours per 24-hour period.Average >=6 hours per 24 hours

    HCPCS E0466 is not covered when used solely as CPAP, auto-titrating PAP, standard BiPAP, AVAPS with or without auto-EPAP, iVAPS, or another respiratory assist device that augments spontaneous breathing or treats sleep apnea or mild to moderate respiratory insufficiency.

    This policy addresses noninvasive home mechanical ventilation and does not address invasive mechanical ventilation delivered through a tracheostomy.

    A request for a noninvasive home ventilator that does not meet the policy’s stated medical-necessity criteria is not medically necessary and will be denied.

    Devices used for CPAP or BiPAP therapy, sleep apnea, or mild to moderate respiratory insufficiency without life-sustaining ventilator dependence beyond respiratory assist device capabilities are not reasonable and necessary under HCPCS E0466.

    Coding and Clinical Thresholds

    Noninvasive Home VentilatorHCPCSCovered
    E0466Noninvasive home ventilator / home ventilatory device
    Respiratory Assist DevicesHCPCS
    E0601CPAP device
    E0470Respiratory assist device, bilevel, without backup rate
    E0471Respiratory assist device, bilevel, with backup rate
    E0472Respiratory assist device, bilevel, with backup rate, used for respiratory insufficiency
    Referenced Medical Necessity Criteriamixed
    A-0893Home Ventilator (Invasive or Noninvasive Interface), MCG Health criterion
    A-0431MCG criteria for BiPAP devices
    A-0994MCG criteria for CPAP devices
    Not Covered UsesHCPCSNot Covered
    E0466Denied when submitted for CPAP or BiPAP therapy or when used solely as a respiratory assist device
    Stable COPD hypercapnia
    ConditionStable COPD with chronic hypercapnia
    PaCO2 threshold> 45 mm Hg (6.0 kPa)
    Clinical statusPatient is stable
    Respiratory failure daytime PCO2
    MeasurementDaytime arterial or capillary PCO2
    Threshold> 45 mm Hg (6.0 kPa)
    Clinical indicationDocumentation of respiratory failure
    Forced vital capacity
    Primary thresholdForced vital capacity < 50% of predicted
    Alternative thresholdForced vital capacity < 80% of predicted
    Additional requirementSymptoms of respiratory failure must accompany the alternative threshold
    Maximum inspiratory pressure
    TestMaximum inspiratory pressure
    Threshold60 cm H2O (5884 Pa) or lower
    UseQualifying evidence of respiratory failure
    Maximum sniff nasal inspiratory pressure
    TestMaximum sniff nasal inspiratory pressure
    Threshold< 40 cm H2O (3923 Pa)
    UseQualifying evidence of respiratory failure
    Nocturnal oxygen saturation
    TestNocturnal oximetry
    Oxygen saturation< 88%
    Duration5 consecutive minutes
    Adult sleep-related hypoventilation
    PCO2 threshold> 55 mm Hg (7.3 kPa)
    Duration10 minutes or longer
    Alternative findingIncrease of 10 mm Hg (1.3 kPa) or greater above the awake supine value resulting in PCO2 > 50 mm Hg (6.7 kPa) for 10 minutes or longer
    Child sleep-related hypoventilation
    Sleeping PCO2 threshold> 50 mm Hg (6.7 kPa)
    Required sleep durationGreater than 25% of total sleep time
    Alternative findingPeak sleep end-tidal PCO2 of 55 mm Hg (7.3 kPa) or greater
    Obesity hypoventilation BMI
    ConditionObesity hypoventilation syndrome
    BMI threshold> 30
    Additional criteriaCPAP must be unsuccessful or not appropriate, with qualifying daytime hypercapnia and sleep-disordered breathing or hypoventilation
    Obesity hypoventilation daytime hypercapnia
    MeasurementDaytime PaCO2
    Threshold> 45 mm Hg (6.0 kPa)
    ExclusionWithout another etiology, such as kyphoscoliosis, lung parenchymal disease, myopathy, or severe hypothyroidism
    Obstructive sleep apnea AHI
    Adult obesity hypoventilationAHI of 5 or greater
    Pediatric mild OSAAHI from 1–5
    Pediatric moderate or severe OSAAHI greater than 5
    Airway pressure requirement
    BiPAP EPAP≤ 10 cm H2O (981 Pa)
    Child CPAP≤ 15 cm H2O (1471 Pa)
    Ventilator PEEP≤ 10 cm H2O (981 Pa)
    Continued device utilization
    Average utilizationAt least 6 hours per 24-hour period
    Documentation periodAt least 30 consecutive days of device data
    Data timingData must begin after 31 days of therapy initiation

    Authorization, Renewal, and Denial Risks

    Prior Authorization

    Initial HVD Prior Authorization

    Obtain prior authorization before dispensing an E0466 noninvasive home ventilator (HVD). Submit the prescription and required clinical documentation supporting ventilator-level medical necessity and the requested device.

    • Specify the HVD brand name and model on the prior authorization request.
    • Include practitioner orders and chart notes documenting chronic respiratory failure, ventilator dependence for life support at least 6 hours per 24-hour period, and ventilator settings.
    Prior Authorization

    Authorization Duration and Renewal

    An initial HVD authorization is valid for a maximum of 3 months. After the initial determination, a new medical-necessity determination with supporting documentation is required every 6 months for continued rental.

    • Track the initial 3-month authorization period.
    • Submit documentation for each subsequent 6-month determination.
    Step Therapy

    Escalation Beyond CPAP or BiPAP

    Escalate from CPAP or standard BiPAP to E0466 only when the member’s chronic respiratory failure or clinical requirements exceed the capabilities of a respiratory assist device. The record must document that CPAP or BiPAP is not clinically appropriate and identify the specific unmet need.

    • Chronic respiratory insufficiency fails to improve with simple BiPAP, or an infant or child does not meet the minimum CPAP body-weight requirement.
    • For pediatric patients, simple BiPAP may be unsuitable because of breath rate, circuit compatibility, inspiratory flow, body-weight, pressure, tidal-volume, trigger-delay, or trigger-sensitivity requirements.
    • Document functionality unavailable with simple BiPAP, such as required alarms, daytime mouthpiece ventilation, unsuitable pressure range, or volume-assured pressure support/volume control.
    • Document other qualifying needs, including portable ventilation for mobility, cough assistance through breath stacking, or ventilation required 24 hours per day.
    Documentation Required

    Initial Supporting Documentation

    Before initial rental, assemble the prescription and supporting documentation required to establish medical necessity for the requested HVD.

    • Completed DMS-679 form specifying the HVD brand name and model on the prior authorization request.
    • Practitioner order and chart notes supporting medical necessity, including ventilator dependence and settings.
    Documentation Required

    Inpatient Dependence and Pulmonary Oversight

    Document that the member has been medically dependent on ventilator support for at least 20 consecutive inpatient days and that home care is safe and feasible under appropriate pulmonary oversight.

    • Obtain direction from a pulmonary physician familiar with the technical and medical components of home ventilator support.
    • Include documentation that the member requires life-sustaining ventilation for at least 6 hours per day.
    Documentation Required

    Continued-Use Documentation

    Reestablish medical necessity every 6 months after the initial 3-month determination. Continued-use records must show persistent disease, compliance, benefit, and qualifying utilization.

    • Complete treating-professional reevaluation no earlier than 61 days after therapy begins.
    • Document persistence of the disease process and that the member is compliant with and benefiting from HVD.
    • Provide at least 30 consecutive days of device data beginning after day 31, demonstrating average use of 6 hours per 24-hour period.
    Documentation Required

    Renewal Examination and Pediatric Weaning Plan

    Renewals require ongoing physician care and timely pulmonary examination documentation. For pediatric members with potentially reversible disease, the pulmonologist must regularly evaluate and document a weaning plan.

    • Ensure the last physical examination by the pulmonologist occurred within 1 year.
    • Submit documentation of a pulmonary examination within 12 months before the renewal start date.
    • Address and evaluate the pediatric ventilator-weaning plan at least annually.
    Prior Authorization

    Renewal Submission Timing

    Within 30 working days before the end of the authorized HVD medical-necessity period, obtain a new prescription and submit a newly completed DMS-679 form signed by the prescribing provider.

    • Monitor authorization expiration dates to avoid late renewal submission.
    • Submit additional information requested during review.
    Denial Risk

    Nonqualifying Use or Insufficient Medical Necessity

    Requests that do not meet the HVD medical-necessity criteria will be denied. E0466 is not qualifying when used solely to augment spontaneous breathing or treat sleep-disordered breathing rather than to provide life-sustaining ventilation beyond respiratory assist device capabilities.

    • CPAP, auto-titrating PAP, standard BiPAP, and AVAPS or iVAPS do not establish ventilator dependence when used for sleep apnea or mild to moderate respiratory insufficiency.
    • Withdrawal of support must place the member at risk of serious harm or death for ventilator-level coverage to be appropriate.
    • A rental period ends when the item is no longer medically necessary, regardless of the authorized rental length.
    Denial Risk

    Failure to Establish Continued Use

    Failure to establish continued use can result in denial of ongoing coverage as not reasonable and necessary. Maintain timely clinical reassessment and objective utilization records for every renewal.

    • Consistent use must average at least 6 hours per 24-hour period.
    • Failure to demonstrate compliance and expected benefit, including the required device-data period, places continued coverage at risk.
    Billing Rule

    Incorrect Coding or Equipment Selection

    Code and dispense the equipment that matches the documented clinical need. Claims for E0466 used to provide CPAP or BiPAP therapy will be denied, and CareSource may seek recoupment when post-payment review identifies a more appropriate code or equipment.

    • Code CPAP or BiPAP therapy according to the applicable CareSource Positive Airway Pressure Devices for Pulmonary Disorders Continued Rental policy.
    • E0466 claims must represent medically necessary HVD use beyond the capabilities of respiratory assist devices.
    • CareSource may request additional records during post-payment review and pursue recoupment for incorrect coding or equipment selection.
    • For E0466 billing under Arkansas Department of Human Services requirements, 1 day equals 1 unit.

    Policy Background

    Noninvasive home mechanical ventilation provides supportive ventilatory assistance through a mask, mouthpiece, or other noninvasive interface for members with stable chronic respiratory failure. It may be used during sleep, during the day, or both, but coverage under E0466 is reserved for members who require mandatory ventilator-level support as the primary life-sustaining source of ventilation. A member is considered noninvasively ventilator-dependent when this support is required for 6 or more hours in a 24-hour period and discontinuation would create a risk of serious harm or death.

    Key Definitions

    Home Mechanical Ventilation (HMV)
    TermHome Mechanical Ventilation (HMV)
    PurposeHome-based ventilatory support devices used in the management of chronic respiratory failure
    Included devicesRespiratory assist devices and medically necessary non-invasive home ventilators, including E0466
    Non-Invasive Ventilation (NIV)
    TermNon-Invasive Ventilation (NIV)
    InterfaceNon-invasive interface, such as a nasal or oronasal mask or mouthpiece
    Support providedPositive airway pressure support that may augment spontaneous breathing or deliver mandatory machine-generated breaths
    Respiratory Assist Devices (RADs)
    TermRespiratory Assist Devices (RADs)
    Device modesStandard BiPAP and volume-targeted pressure support modes such as AVAPS or iVAPS
    Ventilation characteristicAugment spontaneous breathing but do not provide mandatory machine-generated breaths as the primary source of ventilation
    Ventilator-Dependent (Non-Invasive)
    TermVentilator-Dependent (Non-Invasive)
    Required supportMandatory mechanical ventilation is the primary life-sustaining source for 6 or more hours within a 24-hour period
    Risk without supportThe member cannot safely maintain adequate ventilation and discontinuation risks serious harm or death
    Apnea-Hypopnea Index (AHI)
    TermApnea-Hypopnea Index (AHI)
    DefinitionCombined average number of apnea and hypopnea episodes recorded by polysomnogram
    Measurement conditionsRecorded over at least 2 hours without a respiratory device; extrapolation or projection is not permitted

    E0466 Medical Necessity

    Noninvasive home ventilator E0466

    E0466 is medically necessary only when all three requirements are established.

    E0466 medical necessity

    • Qualifying clinical condition: Member meets at least one qualifying clinical condition and all applicable condition-specific criteria.
    • Stable home respiratory status: Airway interface is safe with an acceptable fit; airway pressure requirements are appropriate; settings are stable; continuous invasive monitoring is not required; and trained caregivers are available.
    • Need beyond CPAP or standard BiPAP: CPAP or standard BiPAP is clinically inappropriate or insufficient because of failure of simple BiPAP, pediatric device limitations, unavailable required functionality, need for portable ventilation, need for cough assistance through breath stacking, or need for ventilation 24 hours per day.

    Rental and Purchase Rules

    EquipmentRental ruleDetails
    Noninvasive home ventilator (E0466)RentalInitial approval is valid for a maximum of 3 months. Continued rental requires a new medical necessity determination every 6 months, with supporting documentation.
    EquipmentRental ruleDetails
    Noninvasive home ventilator (E0466)RentalThe rental period ends when the rented item is no longer medically necessary, regardless of the authorized rental length.

    Required Provider Documentation

    Billing Rule

    Maintain supporting documents before billing

    Before billing, obtain and place the required Arkansas DHS supporting documents in the provider’s files. Required records include the prescription; completed DMS-679 specifying the brand name and model; practitioner order and chart notes supporting medical necessity, ventilator settings, and dependence for life support at least 6 hours per day; documentation of at least 20 consecutive inpatient days of medical dependence; and pulmonary physician determination that home care is safe and feasible.

    Billing Rule

    Support continued rental every 6 months

    Support continued rental after the initial 3-month determination by reestablishing medical necessity every 6 months. Submit the reevaluation, persistent disease documentation, compliance and benefit records, at least 30 consecutive days of device data, timely pulmonology examination, and any additional information requested.

    Noncovered Uses

    Not covered under E0466: use solely as CPAP, auto-titrating PAP, standard BiPAP, AVAPS with or without auto-EPAP, or iVAPS for sleep apnea or mild to moderate respiratory insufficiency. These devices and modes are treated as respiratory assist devices when they augment spontaneous breathing and do not, by themselves, establish ventilator dependence. Claims for E0466 submitted for CPAP or BiPAP therapy will be denied as not reasonable and necessary.

    Policy Summary
    PayerCareSource
    PolicyNon-Invasive Home Mechanical Ventilation (E0466)
    Policy CodePolicy PASSE-MM-1702
    Change TypeRevision
    Effective DateNov 1, 2026
    Last ReviewJul 30, 2025
    Next Review DateN/A
    Key ActionSubmit prior authorization with the completed DMS-679 form, prescription, clinical records, ventilator settings, and evidence of required medical dependence and pulmonary oversight.
    SourceLink
    On This Page
    Coverage CriteriaCoding and Clinical ThresholdsAuthorization, Renewal, and Denial RisksPolicy BackgroundKey DefinitionsE0466 Medical NecessityRental and Purchase RulesRequired Provider DocumentationNoncovered Uses

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.